Development of precision medicine approaches based on inter-individual variability of BCRP/<i>ABCG2</i>.
第一作者:
Liming,Chen
第一单位:
Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, CT 06269, USA.
作者:
关键词
3′-UTR, 3′-untranslated region5-aza-C, 5-aza-2′-deoxycytidineABCG2, ATP-binding cassette subfamily G member 2ALL, acute lymphocytic leukemiaAML, acute myeloid leukemiaAUC, area under curveBCRPBCRP, breast cancer resistant proteinEpigeneticsFTC, fumitremorgin CGene polymorphismsH3K4me3, histone H3 lysine 4 trimethylationH3K9me3, histone H3 lysine 9 trimethylationH3S10P, histone H3 serine 10 phosphorylationHDAC, histone deacetylaseHIF-1α, hypoxia inducible factor 1 subunit alphaHIV-1, human immunodeficiency virus type-1HMG-CoA, β-hydroxy-β-methyl-glutaryl-coenzyme AMDR, multidrug resistanceMDR1, multidrug resistance 1NBD, nucleotide binding domainP-gp, P-glycoproteinPhysiologic factorsPrecision medicineRISC, RNA-induced silencing complexSNP, Single nucleotide polymorphismTKI, tyrosine kinase inhibitorTat, transactivator proteinmiRNA, microRNAsiRNA, small RNA interference
DOI
10.1016/j.apsb.2019.01.007
PMID
31384528
发布时间
2020-10-01
- 浏览8
Acta pharmaceutica Sinica. B
2019年9卷4期
659-674页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



